首页> 外文期刊>Journal of nuclear cardiology: official publication of the American Society of Nuclear Cardiology >Assessment of myocardial perfusion with real-time myocardial contrast echocardiography: Methodology and clinical applications.
【24h】

Assessment of myocardial perfusion with real-time myocardial contrast echocardiography: Methodology and clinical applications.

机译:对实时心肌造影超声心动图的评估对心肌灌注:方法论和临床应用。

获取原文
获取原文并翻译 | 示例
           

摘要

Real-time myocardial contrast perfusion imaging (RTMCI) with echocardiography is a promising technique for evaluation of patients with known or suspected coronary artery disease. The technique is based on the utilization of small (<10 mum) microbubbles, which are capable of crossing the pulmonary circulation after intravenous injection. Unlike radioactive isotopes, which are taken actively or diffuse passively in the myocytes, myocardial contrast agents remain extracellularly in the capillaries and present a measure of the myocardial capillary blood volume and microvascular integrity. RTMCI has been shown to be a safe and feasible method for the assessment of myocardial perfusion at rest and with pharmacologic stress. Recent studies have shown the value of RTMCI with dobutamine stress in improving overall and regional detection of coronary artery disease and detecting of abnormalities at submaximal stress, therefore improving sensitivity in patients who are unable to achieve the target heart rate. The advantages of the technique include the ability to assess perfusion at bedside in one setting, simultaneous assessment of myocardial function, shorter imaging time, no need for ionizing irradiation, immediate availability of the results, and the ability to determine the ischemic threshold. Recent studies have shown that RTMCI improves the prognostic utility of standard dobutamine stress in addition to wall motion analysis. Patients with normal perfusion had a better outcome than those with normal wall motion. The combination of abnormal wall motion and perfusion identified patients at greatest risk of death and nonfatal myocardial infarction. Perfusion abnormalities were also shown to predict short-term cardiac events in patients presenting to the emergency department with chest pain and no ST-segment elevation. Refinement of imaging techniques is expected to improve the specificity of RTMCI, particularly in differentiating true perfusion defects from artifacts. This review will discuss the physiologic basis,methodology, clinical utility, and limitations of RTMCI in the assessment of patients with known or suspected coronary artery disease.
机译:具有超声心动图的实时心肌对比度灌注成像(RTMCI)是评估已知或疑似冠状动脉疾病患者的有希望的技术。该技术基于利用小(<10毫米)微泡,其能够在静脉内注射后穿过肺循环。与放射性同位素不同,其被动地在肌细胞中被动地脱落,心肌造影剂在毛细血管中保持细胞内酯,并呈现心肌毛细血管血量和微血管完整性的衡量标准。 RTMCI已被证明是一种安全可行的方法,用于评估休息和药理学应激的心肌灌注。最近的研究表明RTMCI与多元胺应激改善冠状动脉疾病的整体和区域检测和潜水胁迫异常检测,从而提高了无法达到目标心率的患者的敏感性。该技术的优点包括在一个设置中评估床边的灌注,同时评估心肌功能,较短的成像时间,无需电离照射,即确定结果的即时可用性,以及确定缺血阈值的能力。最近的研究表明,除了壁运动分析之外,RTMCI还改善了标准Dobutamine应力的预后效用。正常灌注患者具有比具有正常壁运动的患者更好的结果。异常壁运动和灌注的组合鉴定了最大的死亡风险和非缺乏心肌梗死的患者。还显示灌注异常,以预测患者患有胸痛和胸部疼痛的患者的短期心脏事件,没有ST段仰角。预期成像技术的细化会改善RTMCI的特异性,特别是在区分从伪影中的真正灌注缺陷。本综述将讨论在评估已知或疑似冠状动脉疾病的患者中RTMCI的生理基础,方法,临床实用性和局限性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号